FIELD: medicine.
SUBSTANCE: invention concerns experimental medicine, namely to experimental pulmonology and can be used at creation of model of chronic obstructive disease of lungs (COLD). For this purpose inhalation oxidiser is injected to the laboratory animals: nitrogen dioxide in concentration of 30-40 mg/m3. Inhalations are carried out daily within 1.5-2 hours not less than 60 days.
EFFECT: adequate reproducibility of model at 100 % of survival rate of animals.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MEDICAL REHABILITATION OF PATIENTS OF WORKING AGE IN EARLY RECOVERY PERIOD OF ISCHEMIC STROKE WITH ACCOMPANYING OBSTRUCTIVE CHRONIC RESPIRATORY SYSTEM DISTURBANCE OUTSIDE EXACERBATION | 2019 |
|
RU2714214C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE | 2011 |
|
RU2464007C1 |
| METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600833C1 |
| METHOD TO INOCULATE LABORATORY ANIMALS BY INDUSTRIAL DUST FOR SILICOSIS SIMULATION | 2013 |
|
RU2546096C1 |
| METHOD OF TREATING OCCUPATIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF MINING AND METALLURGICAL INDUSTRY WORKERS | 2015 |
|
RU2596892C1 |
| METHOD FOR EXPERIMENTAL SIMULATION OF INFLAMED PARANASAL SINUSES ACCOMPANYING CHRONIC TOBACCO SMOKING IN RATS | 2012 |
|
RU2522954C2 |
| COMBINATION OF METHYLXANTHINE COMPOUNDS AND STEROIDS FOR TREATMENT OF CHRONIC RESPIRATORY DISEASES | 2006 |
|
RU2395285C2 |
| METHOD FOR CARRYING OUT EARLY STAGE NON-INVASIVE DIAGNOSIS OF BRONCHIAL REMODELING PROCESSES IN CHRONIC OBSTRUCTIVE LUNG DISEASE IN MALE CASES | 2004 |
|
RU2285264C2 |
| ALPHA-1-ANTITRYPSIN FOR TREATING EPISODES OF PULMONARY DISEASE AGGRAVATIONS | 2007 |
|
RU2472524C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CHRONIC OBSTRUCTIVE LUNG DISEASE AND BRONCHIAL ASTHMA | 2011 |
|
RU2483677C1 |
